Taken together, these data show that inhibition of Notch1 signaling can regulate the expression of fatty acid oxidation genes and may provide therapeutic strategies in obesity-induced hepatic steatosis. Here, NOTCH1 is linked to obesity due to melanocortin 4 receptor deficiency.